Status:
COMPLETED
Pandemic Influenza Plasmid DNA Vaccines (Needle)
Lead Sponsor:
Vical
Conditions:
Influenza
Eligibility:
All Genders
18-45 years
Phase:
PHASE1
Brief Summary
The trial will enroll up to 57 subjects. Qualified normal healthy volunteers will be enrolled in the study to receive the vaccine or placebo vaccine. Subjects will receive 2 vaccinations with a needle...
Eligibility Criteria
Inclusion
- 18 to 45 years of age
- Able to provide informed consent and be followed for 6 months
Exclusion
- No immunomodulatory therapy within the past 6 months
- No evidence of immunodeficiency or pregnancy
- No laboratory or evidence of clinically significant medical disease
- No history of previous pDNA immunization
- No influenza immunization within the past 30 days
- No blood donations within 30 days of screening visit
- No history of bleeding disorder
- No use of aspirin and/or anticoagulants within 2 weeks of the administration of the investigational vaccines
Key Trial Info
Start Date :
August 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT00709800
Start Date
August 1 2007
Last Update
February 12 2009
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Accelovance
San Diego, California, United States, 92108
2
SNBL
Baltimore, Maryland, United States, 21201
3
SUNY at Stonybrook, Stony Brook Medical Center
Stony Brook, New York, United States, 11794-8153